Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR (2009) <br />Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB<br /><i>J Alzheimers Dis</i> <b>16</b>: 29<br /><br />Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B (1998) <br />Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease<br /><i>Journal of Clinical Pharmacology</i> <b>38</b>: 236<br /><br />Baumann RJ, Markesbery WR (1982) <br />Santavuori disease: diagnosis by leukocyte ultrastructure<br /><i>Neurology</i> <b>32</b>: 1277<br /><br />